Detection of HBV, PCNA and GST-π in hepatocellular carcinoma and chronic liver diseases

Table 1 Detection of hepatitis B virus, PCNA and GST-π in hepatocellular carcinoma and chronic liver diseases

Group	HBsAga	HBVDNAb	PCNAc	GST-πd
1. Normal liver tissue	0/9 (0)	0/9 (0)	0/5 (0)	0/5 (0)
2.Chronic hepatitis	15/24 (62.5)	12/16 (75.0)	8/23 (34.8)	4/16 (25.0)
3.Liver cirrhosis	16/25 (64.0)	15/18 (83.3)	14/19 (73.7)	3/17 (17.6)
4.Paratumorous tissue	16/22 (72.7)	12/14 (85.7)	13/15 (86.7)	8/15 (53.3)
5.HCC	14/31 (45.2)	9/14 (64.3)	15/15 (100)	9/15 (60.0)

HCC: hepatocellular carcinoma; HBsAg: Hepatitis B surface antigen; HBVDNA: hepatitis B virus DNA; PCNA: prolifer-ating cell nuclear antigen; GST-π: glutathione S-transferases.

^aP < 0.05, 5 vs 4, P < 0.01, 1 vs 4;

^bP < 0.01, 1 vs 4;

^cP < 0.01, 1 vs 4, 2 vs 4;

^dP < 0.05, 3 vs 4, P < 0.01, 1 vs 4.